Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,064.36 +53.76 (+1.07%) Dow
38,481.29 +241.31 (+0.63%) Nasdaq
15,672.42 +221.11 (+1.43%) Bitcoin USD
66,753.48 +944.55 (+1.44%) CMC Crypto 200
1,440.54 +25.78 (+1.82%)
Getinge AB (publ) (GNGBY)
| Previous close | 21.02 |
| Open | 21.13 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 20.99 - 21.28 |
| 52-week range | 16.21 - 25.75 |
| Volume | |
| Avg. volume | 6,391 |
| Market cap | 5.796B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 27.64 |
| EPS (TTM) | 0.77 |
| Earnings date | N/A |
| Forward dividend & yield | 0.42 (1.95%) |
| Ex-dividend date | 23 Apr 2024 |
| 1y target est | N/A |
GuruFocus.comGetinge AB's Dividend Analysis
Getinge AB (GNGBY) recently announced a dividend of $0.42 per share, payable on 2024-05-14, with the ex-dividend date set for 2024-04-23. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Getinge AB's dividend performance and assess its sustainability.
- Reuters
Medical gear maker Getinge beats profit expectations, shares jump
(Reuters) -Medical equipment maker Getinge reported a smaller than expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products. Its quarterly earnings before interest, tax and amortisation (EBITA), adjusted for items affecting comparability, fell 13.4% from a year earlier to 842 million Swedish crowns ($77 million), but exceeded a consensus of 770 million cited by J.P.Morgan. Getinge has struggled to resolve quality problems with sterile packaging of products for heart-lung support systems and with its heart pumps that have squeezed its margins and knocked its shares since the second quarter last year.
- Reuters
Medical gear maker Getinge's Q4 misses forecasts, shares fall
STOCKHOLM (Reuters) -Swedish medical equipment maker Getinge reported on Thursday a smaller than expected rise in fourth-quarter earnings as costs squeezed margins and its organic order intake fell, sending its shares down. Operating profit was 1.14 billion crowns ($109 million) against a year-ago 828 million and a mean forecast of 1.36 billion in an LSEG poll of analysts, on organic sales growth of 10%. Getinge said this was mainly due to a tough year-ago comparison in connection with China lifting pandemic restrictions.
